Decide the next step when Crohn's symptoms change
More diarrhea or abdominal pain between specialist visits can raise concern for a flare, infection, or a complication. An Ondoc licensed clinician can review symptoms and help coordinate evaluation; Insurance or $50 self-pay.
What your visit can cover
- Symptom and medication review to guide urgency of gastroenterology follow-up
- Blood or stool testing considered for inflammation, anemia, or infection
- Nutrition and hydration concerns assessed with specialist coordination
When to be seen in person
Severe abdominal pain with bloating, vomiting, or inability to pass stool or gas may indicate obstruction and needs emergency care. Fever with painful swelling near the anus needs urgent assessment for an abscess.
About Crohn's disease
Crohn's disease is a form of inflammatory bowel disease that can affect any part of the digestive tract. Persistent diarrhea, abdominal pain, weight loss, and fatigue may occur. Diagnosis usually requires gastroenterology evaluation with tests such as stool studies, imaging, or endoscopy. Treatment depends on disease location and severity and may require specialist medicines or surgery. An online consultation can review existing records and discuss evaluation or referral needs; it does not provide endoscopy or guarantee specialist treatment. Severe pain, dehydration, or significant bleeding needs urgent in-person care.
Questions about Skyrizi for Crohn’s disease
Skyrizi (risankizumab) is a biologic used for moderately to severely active Crohn’s disease. It also treats other conditions, but the dosing and care plan for psoriasis are not interchangeable with Crohn’s treatment. Crohn’s induction involves infusions followed by maintenance injections; an online prescription does not provide the infusion itself.
Starting treatment is different from continuing an established plan
Your clinician needs to know the diagnosis, previous therapies, current symptoms and the plan from your treating team. TB screening, infection history, vaccination considerations and liver testing may be relevant. These are clinical decisions during care, not a self-assessment you must complete before booking. Do not change biologic dosing or stop treatment on the strength of a web page.
Ondoc can discuss the medication and your symptoms, review available results and coordinate specialist follow-up or treatment when appropriate. Prescription decisions remain with the clinician; access, prior authorization and infusion arrangements depend on the drug benefit and performing facility. Worsening symptoms may be infection or a complication rather than a routine flare.
Continue with the same concern: Skyrizi and Crohn’s care · Ulcerative colitis (a different IBD diagnosis).
Reference: Crohn’s & Colitis Foundation: risankizumab.